Global Transdermal Patches Market Forecast (2018-2023) by Type, Application and Geography - ResearchAndMarkets.com

December 3, 2018

DUBLIN--(BUSINESS WIRE)--Dec 3, 2018--The “Global Transdermal Patches Market - Forecasts from 2018 to 2023” report has been added to ResearchAndMarkets.com’s offering.

The global transdermal patches market is expected to register a CAGR of 4.85% during the forecast period of 2017-2023.The growth in the market may be attributed to its advantages such as ease of administration, non-invasive and painless administration of medication and prolonged activity of the drug. The constant diffusion of the also helps to achieve steadier blood levels as compared to injectable and most oral medications.Peak plasma levels of drugs are reduced, leading to decreased side effects because of direct-to-bloodstream delivery while bypassing the liver’s metabolic activity ensuring the less amount of drug to be given, thereby, further boosting the market for the transdermal patches during the given forecast period.However, inability of the skin to absorb large range of medications and development of contact dermatitis in few cases might restrict the market for the transdermal patches during the given time frame.

Key Topics Covered

1. Introduction

2. Research Methodology

3. Key Findings of the Study

4. Market Dynamics

5. Global Transdermal Patches Market Forecast by Type

6. Global Transdermal Patches Market Forecast by Application

7. Global Transdermal Patches Market Forecast by Geography

8. Competitive Intelligence

9. Company Profiles

AdhexPharmaProSolus, Inc.TapemarkTesa Labtec GmbHNitto Denko CorporationNoven Pharmaceuticals, Inc. (Wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc.)LTS Lohmann Therapie-Systeme AGMedherant LimitedCorium Int

For more information about this report visit https://www.researchandmarkets.com/research/847lvf/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181203005363/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Transdermal and Transmucosal Drug Delivery



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/03/2018 05:09 AM/DISC: 12/03/2018 05:09 AM


Update hourly